FR2934698B1 - Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. - Google Patents

Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Info

Publication number
FR2934698B1
FR2934698B1 FR0804414A FR0804414A FR2934698B1 FR 2934698 B1 FR2934698 B1 FR 2934698B1 FR 0804414 A FR0804414 A FR 0804414A FR 0804414 A FR0804414 A FR 0804414A FR 2934698 B1 FR2934698 B1 FR 2934698B1
Authority
FR
France
Prior art keywords
disease
prognosis
diagnosis
prostate cancer
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0804414A
Other languages
English (en)
Other versions
FR2934698A1 (fr
Inventor
Karine Auribault
Jean Denis Muller
Tassin Geraldine Cancel
Olivier Cussenot
Stephane Gazut
Nicolas Gilardi
David Mercier
Jean Philippe Poli
Emmanuel Ramasso
Frederic Suard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP, Commissariat a lEnergie Atomique CEA filed Critical CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Priority to FR0804414A priority Critical patent/FR2934698B1/fr
Priority to PCT/EP2009/059930 priority patent/WO2010012823A1/fr
Priority to CA2733385A priority patent/CA2733385A1/fr
Priority to US13/056,746 priority patent/US20110301863A1/en
Priority to CN2009801386590A priority patent/CN102171698A/zh
Priority to EP09781338A priority patent/EP2318971A1/fr
Publication of FR2934698A1 publication Critical patent/FR2934698A1/fr
Application granted granted Critical
Publication of FR2934698B1 publication Critical patent/FR2934698B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Evolutionary Computation (AREA)
  • Microbiology (AREA)
  • Software Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioethics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0804414A 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. Expired - Fee Related FR2934698B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0804414A FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.
PCT/EP2009/059930 WO2010012823A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede
CA2733385A CA2733385A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede
US13/056,746 US20110301863A1 (en) 2008-08-01 2009-07-31 Prediction method for the screening, prognosis, diagnosis or therapeutic response of prostate cancer, and device for implementing said method
CN2009801386590A CN102171698A (zh) 2008-08-01 2009-07-31 前列腺癌的筛查、预后、诊断或治疗反应的预测方法和实施所述方法的装置
EP09781338A EP2318971A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804414A FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Publications (2)

Publication Number Publication Date
FR2934698A1 FR2934698A1 (fr) 2010-02-05
FR2934698B1 true FR2934698B1 (fr) 2011-11-18

Family

ID=40394423

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0804414A Expired - Fee Related FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Country Status (6)

Country Link
US (1) US20110301863A1 (fr)
EP (1) EP2318971A1 (fr)
CN (1) CN102171698A (fr)
CA (1) CA2733385A1 (fr)
FR (1) FR2934698B1 (fr)
WO (1) WO2010012823A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2611943B1 (fr) * 2010-09-03 2017-01-04 Wake Forest University Health Sciences Procédés et compositions pour la corrélation de marqueurs génétiques au risque de cancer de la prostate
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
US8924325B1 (en) * 2011-02-08 2014-12-30 Lockheed Martin Corporation Computerized target hostility determination and countermeasure
EP2823427B1 (fr) 2012-03-05 2020-12-16 OY Arctic Partners AB Systèmes informatiques, procédés et support de stockage lisible par ordinateur pour prédire le risque de volume de la glande prostatique
US9939533B2 (en) 2012-05-30 2018-04-10 Lucerno Dynamics, Llc System and method for the detection of gamma radiation from a radioactive analyte
US9002438B2 (en) 2012-05-30 2015-04-07 Lucerno Dynamics System for the detection of gamma radiation from a radioactive analyte
CN102899322A (zh) * 2012-11-02 2013-01-30 复旦大学 一种与前列腺癌易感性相关的单核苷酸多态性位点及其应用
CN102994495A (zh) * 2012-11-02 2013-03-27 上海长海医院 一种与前列腺癌易感性相关的单核苷酸多态性位点及其应用
MY182773A (en) 2012-11-20 2021-02-05 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
EP2759605B1 (fr) * 2013-01-25 2018-11-14 Signature Diagnostics AG Procédé permettant de prédire une manifestation de mesure d'un résultat d'un patient atteint d'un cancer
EP3022670B1 (fr) * 2013-07-15 2020-08-12 Koninklijke Philips N.V. Classification de la réponse d'un tissu d'intérêt à un traitement thérapeutique basée sur l'imagerie
RU2720148C9 (ru) 2014-03-11 2020-09-28 Пхадиа Аб Способ обнаружения солидной злокачественной опухоли
EP3123381B1 (fr) 2014-03-28 2023-10-11 Opko Diagnostics, LLC Compositions et procédés relatifs au diagnostic du cancer de la prostate
JP6312253B2 (ja) * 2014-11-25 2018-04-18 学校法人 岩手医科大学 形質予測モデル作成方法および形質予測方法
EP3318878A3 (fr) 2015-03-27 2018-07-11 Opko Diagnostics, LLC Standards d'antigènes prostatiques et leurs utilisations
KR20170061222A (ko) * 2015-11-25 2017-06-05 한국전자통신연구원 건강데이터 패턴의 일반화를 통한 건강수치 예측 방법 및 그 장치
US11416622B2 (en) * 2018-08-20 2022-08-16 Veracode, Inc. Open source vulnerability prediction with machine learning ensemble
CN110604550B (zh) * 2019-09-24 2022-06-21 广州医科大学附属肿瘤医院 一种肿瘤放疗后正常组织器官并发症预测模型的建立方法
CN111582370B (zh) * 2020-05-08 2023-04-07 重庆工贸职业技术学院 一种基于粗糙集优化的脑转移瘤预后指标约简及分类方法
WO2023205842A1 (fr) * 2022-04-27 2023-11-02 Genetic Technologies Limited Procédés d'évaluation du risque de développer un cancer de la prostate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092888A1 (en) * 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US7908091B2 (en) * 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
CA2671267A1 (fr) * 2006-11-30 2008-06-05 Navigenics Inc. Procedes et systemes d'analyse genetique

Also Published As

Publication number Publication date
CN102171698A (zh) 2011-08-31
WO2010012823A1 (fr) 2010-02-04
US20110301863A1 (en) 2011-12-08
CA2733385A1 (fr) 2010-02-04
EP2318971A1 (fr) 2011-05-11
FR2934698A1 (fr) 2010-02-05

Similar Documents

Publication Publication Date Title
FR2934698B1 (fr) Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.
Cohn et al. The heterogeneity of cellular senescence: insights at the single-cell level
US11574712B2 (en) Origin protected OMIC data aggregation platform
Bradford et al. Patient and clinical characteristics that heighten risk for heart failure readmission
Gasevic et al. Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis
EP1724698A3 (fr) Système et procédé de prédiction de l'effet du traitement, et programme informatique correspondant
WO2008073572A3 (fr) Système et procédé de transactions de règlement de lots
Sweeney-Reed et al. Thalamic theta phase alignment predicts human memory formation and anterior thalamic cross-frequency coupling
Pross et al. Quality and resource efficiency in hospital service provision: A geoadditive stochastic frontier analysis of stroke quality of care in Germany
Sadkovsky et al. PPPM (Predictive, Preventive and Personalized Medicine) as a new model of the national and international healthcare services and thus a promising strategy to prevent a disease: from basics to practice
CN109994185A (zh) 一种验证营养素是否适合个性化病人的方法
Venkatesan et al. Diagnostic and therapeutic approach of artificial intelligence in neuro-oncological diseases
Fisher et al. 5‐HTTLPR differentially predicts brain network responses to emotional faces
Leong et al. Five-year survival rate of breast cancer patients in Brunei Darussalam.
Koff et al. Prognostic modeling in diffuse large B‐cell lymphoma in the era of immunochemotherapy: Where do we go from here?
WO2006065940A3 (fr) Identification et utilisation de marqueurs pronostiques et predictifs dans le traitement du cancer
Martin et al. Telepathology: a new tool of pathology? Presentation of a French national network.
Li et al. EPIG-Seq: extracting patterns and identifying co-expressed genes from RNA-Seq data
Brar et al. Management of diffuse low-grade glioma: the renaissance of robust evidence
Akhdar et al. HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)
Johnson et al. Application of a bioinformatics-based approach to identify novel putative in vivo BACE1 substrates
Böcking Comparability of tumor-cytogenetics and-DNA-cytometry
Acquavella et al. Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
Shahraki et al. Smart Acute Stroke Quality Registry Design-Data Elements Identification.
Kollins From risk prediction to action: leveraging electronic health records to improve pediatric population mental health

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20180430